Skip to content
Home/Companies/Pharma/Apurano
Apurano

Apurano

Pharma·Germany·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Apurano?

Apurano is a German Pharma company, currently owned by Capmont since 2023.

Hand-verified · updated 2026-07-07

Open JSON · CC-BY
Capmont
Investor
Capmont
Capmont Private Equity · 2006 · Evergreen

Key facts

HQGermany
SectorPharma
StatusActive
Websiteapurano.de

More from Capmont Private Equity

Other portfolio companies in the same fund.

Dyneon
Active
IndustrialsGermany· 2026
Binetti Cablaggi
Active
IndustrialsItaly· 2025
Deutsche Fertighaus Holding
Active
ConsumerGermany· 2025
Liposphere
Liposphere
Active
MedTechGermany· 2025
Quad Europe
Active
Business ServicesGermany· 2025
Rockfin
Rockfin
Active
EnergyPoland· 2025

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Apurano?

Apurano is currently owned by Capmont, through Capmont Private Equity, since 2023.

When did Capmont acquire Apurano?

Capmont acquired Apurano in 2023.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue